Adaptive Biotechnologies Corporation
$1.5M 3,663 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Servier Pharmaceuticals LLC
Servier Pharmaceuticals LLC reported $1,483,387.62 across General Payments, Research, and Ownership to 5,634 physicians and teaching hospitals across 5,634 transactions.
- $1.5M
- All-tracks total
- 5,634
- Transactions
- 5,634
- Recipients
- +$425.4K
- General Payments vs PY2023
Servier Pharmaceuticals LLC reported $1,483,387.62 across all CMS Open Payments tracks (General + Research + Ownership) to 5,634 physicians and teaching hospitals in Program Year 2024 - ranking #530 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,483,387.62, averaging $263.29 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer servier-pharmaceuticals-llc Servier Pharmaceuticals LLC
$1.5M · #530/1,925 · 0.0% industry · PY2024
- TOT $1.5M
- RANK #530
- SHARE 0.0%
- TXN 5,634
- RCP 5,634
- CAT 5
- GEN $1.5M
- ΔGEN +$425.4K
- TOP1 10.8%
- PY 2024
Volume peers
Nearest volume peer: Adaptive Biotechnologies Corporation ($1.5M)
Servier Pharmaceuticals LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Servier Pharmaceuticals LLC's CMS-reported General Payments increased by $425.4K (+40.2%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: SERVIER PHARMACEUTICALS LLCPY2023: SERVIER PHARMACEUTICALS LLCPY2024: SERVIER PHARMACEUTICALS LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $1,057,938.21
- PY2024
- $1,483,387.62
What the Data Shows for Servier Pharmaceuticals LLC
Servier Pharmaceuticals LLC ranks #530 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $1,483,387.62 across 5,634 transactions to 5,634 physicians and teaching hospitals - $263.29 per transaction and $263.29 per recipient on average.
The 5-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $888.6K, accounting for 59.9% of this company's General Payments and 259 transactions.
General Payment Breakdown by Type
Across 5 types of general payments, Servier Pharmaceuticals LLC's largest category was "Consulting Fee" at $888.6K - 59.9% of General Payments.
Servier Pharmaceuticals LLC reports 5 general-payment categories - the top three are Consulting Fee (59.9%), Space Rental or Facility Fees (15.8%), and Food and Beverage (11.4%). The remaining 2 categories make up 12.9% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Servier Pharmaceuticals LLC divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $888.6K | 259 | 59.9% |
| Space Rental or Facility Fees | $235.0K | 24 | 15.8% |
| Food and Beverage | $168.4K | 5,016 | 11.4% |
| Compensation for Services Other Than Consulting | $100.5K | 56 | 6.8% |
| Travel and Lodging | $91.0K | 279 | 6.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $253,169.67 (17.1%) of $1,483,387.62 in this company's General Payments records across 3,464 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Servier Pharmaceuticals LLC
The five named recipients with the highest reported General Payments from this company
- 1
Moffitt Cancer Center
$159,836.20 across 9 reported transactions
- 2
Rami Komrokji
$25,729.67 across 16 reported transactions
- 3
Harry Erba
$23,583.10 across 20 reported transactions
- 4
Yoshie Umemura
$23,250.91 across 15 reported transactions
- 5
Rimas Lukas
$20,769.79 across 12 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Servier Pharmaceuticals LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Servier Pharmaceuticals LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Servier Pharmaceuticals LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Cook Research Incorporated
$1.5M 55 recipients
Compare payment profiles
FUJIFILM Healthcare Americas Corporation
$1.5M 993 recipients
Compare payment profiles
CardioFocus, Inc.
$1.5M 202 recipients
Compare payment profiles
Artivion, Inc.
$1.5M 1,638 recipients
Compare payment profiles
Vital Connect, Inc
$1.5M 832 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.